The biological significance of “Enteroglucagon”. Present status

This publication has 22 references indexed in Scilit:

• Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion
  FEBS Letters, 1985
• Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileum
  FEBS Letters, 1982
• Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileum
  FEBS Letters, 1982
• Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin-stimulated acid secretion in rats
  Bioscience Reports, 1982
• Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
• ‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action
  Bioscience Reports, 1981
• Glucagon precursors identified by immunoprecipitation of products of cell-free translation of messenger RNA
  Diabetes, 1980
• Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1980
• Purification and Characterization of a Protein from Porcine Gut with Glucagon-Like Immunoreactivity
  Hormone and Metabolic Research, 1976
• Gut glucagon: A common receptor site with pancreatic glucagon in liver cell plasma membranes
  FEBS Letters, 1973